Key Insights

Highlights

Success Rate

67% trial completion

Treatment Research

7 treatments under study, led by Intravenous Nitroglycerin

Research Leaders

6 sponsors active, led by University Of California San Francisco

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

16.7%

1 terminated out of 6 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results67% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
P 4 (1)

Trial Status

Recruiting2
Completed2
Terminated1
Unknown1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Intravenous Nitroglycerin1
  • Standard Active Management Of Second Stage1
  • Obstetric Lubricant Gel1
  • Continuous Maternal Feedback1
  • Straining Types1

Active Sponsors

  • University Of California San Francisco1
  • Clinical Innovations Llc1
  • Hospital St Joseph Marseille France1
  • Universidad Nacional Autonoma De Honduras1
  • Ospedale Degli Infermi Di Biella1

Related Conditions

  • Newborn Vitality1
  • Other Specified Trauma To Perineum And Vulva During Delivery1
  • Prolonged Second Stage Of Labor Due To Poor Maternal Effort1

Activity Timeline